PMC6297265_01
Necrotizing gingivitis and mucosal ulceration indicating bone-marrow suppression and incipient agranulocytosis during low-dose MTX treatment.
gr1.jpg
PMC6297265_01_gr1.jpg
fig1
Medical examination found necrotizing gingivitis, mucosal erosions (Fig 1), and purpuric skin lesions.
PMC6297265_02
PMC6297265_03
Monomorphic erosions of all pre-existing psoriatic plaques as an early sign of MTX toxicity and myelosuppression.
gr2.jpg
PMC6297265_03_gr2.jpg
fig2
Clinical examination found disseminated sharply demarcated monomorphic erosions with hemorrhagic crusts in all prior psoriatic skin lesions (Fig 2).